Hercules receives Eurostars grant to develop CB7993113 for breast cancer
3 November 2015 | By Victoria White
Hercules has said that the Eurostars grant will enable the company to advance CB7993113 through preclinical development towards clinical trials in patients with triple negative breast cancer...